Home › Urothelial (Transitional Cell) Carcinoma › New York › Queens
Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Queens, NY
Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Queens. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- START New York Long Island LLC, Lake Success · 9 mi ang layo
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi ang layo
DBC-664 in Adult Patients With Solid Tumors
Nagre-recruitPhase 1
- START New York, Lake Success · 9 mi ang layo
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Nagre-recruitObservasyonal na pag-aaral
- The Feinstein Institutes for Medical Research, Lake Success · 9 mi ang layo
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Nagre-recruitPhase 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi ang layo
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Nagre-recruitPhase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi ang layo
A Study of GEN1106 in Participants With Solid Tumors
Nagre-recruitPhase 1
- START New York Long Island LLC, Lake Success · 9 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi ang layo
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Nagre-recruitPhase 1/2
- START New York Long Island, New Hyde Park · 9 mi ang layo
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- Clinical Research Alliance, Inc, Westbury · 14 mi ang layo
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Nagre-recruitPhase 2
- MSK nassau, Uniondale · 13 mi ang layo
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Nagre-recruitPhase 1
- Start New York, LLC, Lake Success · 9 mi ang layo
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Nagre-recruitObservasyonal na pag-aaral
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi ang layo
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Nagre-recruitPhase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi ang layo
Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod
- Nashville, TN23 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX19 pag-aaral
- Dallas, TX18 pag-aaral
- Edison, NJ18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Chicago, IL14 pag-aaral
- Arlington, VA12 pag-aaral
- Boston, MA11 pag-aaral
- San Antonio, TX11 pag-aaral
- Austin, TX10 pag-aaral
- Orange, CA10 pag-aaral
Iba pang pag-aaral sa Queens
- Kanser sa Suso64 pag-aaral
- Non-Small Cell Lung Cancer49 pag-aaral
- Colorectal Cancer31 pag-aaral
- Metastatic Cancer28 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser sa Prostate27 pag-aaral
- Kanser (lahat ng uri)26 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Kanser sa Baga22 pag-aaral
- Acute Myeloid Leukemia21 pag-aaral
- Multiple Myeloma20 pag-aaral
- Kanser sa Pancreas20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.